{
  "url": "https://openlegislation.uk/draft-misuse-of-drugs-act-1971-amendment-no-2-order-2017/article-3",
  "json_url": "https://openlegislation.uk/draft-misuse-of-drugs-act-1971-amendment-no-2-order-2017/article-3.json",
  "legislation": "ukdsi/2017/9780111159149",
  "legislation_title": "The Misuse of Drugs Act 1971 (Amendment) (No. 2) Order 2017",
  "legislation_url": "https://openlegislation.uk/draft-misuse-of-drugs-act-1971-amendment-no-2-order-2017",
  "path": "article/3",
  "kind": "article",
  "number": "3",
  "heading": "Amendment to the Misuse of Drugs Act 1971",
  "text": "In paragraph 1(a) of Part 2 (which specifies the drugs which are subject to control under that Act as Class B drugs) after “Methylphenobarbitone” insert—\n“N-methyl-1-(thiophen-2-yl)propan-2-amine (methiopropamine or MPA).”.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/ukdsi/2017/9780111159149/article/3",
    "retrieved_at": "2026-10-30T15:06:17.811212+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}